Aqualung Therapeutics Company
Aqualung Therapeutics is developing a novel, anti-inflammatory monoclonal antibody strategy to treat serious unchecked inflammation.
Technology:
Other
Industry:
P4 Medicine
Headquarters:
Others
Founded Date:
2010-01-01
Employees Number:
1-10
Investors Number:
2
Total Funding:
$19.8M
Last Funding Type:
Grant
Register and Claim Ownership